NR3C2 and hypertensive disorder: It has been utilized in clinical trials to treat heart and kidney disease connected to hypertension and other chronic diseases by blocking MR signaling with MR antagonists (MRAs), which suppresses fibrosis in these organs as MRAs likely have cardio-protective effects by directly blocking cardiac and vascular MR (72, 73).